Johnson & Johnson to Resume Manufacturing of Cosmetics at the Mulund Plant
MUMBAI, September 24, 2013
MUMBAI, September 24, 2013 /PRNewswire/ --
The Bombay High Court today allowed baby products manufacturer Johnson &
Johnson to restart the manufacturing of baby powder at its Mulund unit, which
had been stopped upon the order of Maharashtra Food and Drug Administration.
The Honourable High Court passed this judgment after due consideration of all
facts related to the case. The court also found the company's offer to test
the batches of baby powder in question, reasonable. Further, there was no
scientific foundation that there were any carcinogens present in that batch of
"Nothing is more important to us than the well-being of consumers, and we see
this outcome as a significant step in restoring their confidence. We will
continue to work closely with Maharashtra FDA, and provide India with safe,
high quality products that help people care for themselves and their
families," said a Johnson & Johnson, India spokesperson.
For the past 100 years, Johnson & Johnson has earned the trust of over one
billion families and healthcare professionals. Our commitment to safety and
health of our consumers has and will always be, our top priority.
About Johnson's® Baby:
With a legacy of over 100 years, Johnson's® Baby is a market leader in its
category, driving the trends and developments in the baby space. Johnson's®
Baby aspires to touch every baby in India with brands operating in the widest
consumer spectrum. From premium products like Johnson's® Baby Top-To-Toe® Wash
- the first ever liquid bath product for babies, Johnson's® Baby Skincare
Wipes to low cost outlay packs of soaps and powders that are more accessible
to consumers at the bottom of the pyramid, Johnson's® Baby's offerings cover
an entire range.
Primary Media Contact: Ransom DSouza, email@example.com , 91-9820234999
Secondary Media Contact: Romil Zaveri, firstname.lastname@example.org , 91-9819423527
Press spacebar to pause and continue. Press esc to stop.